查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1442597

全球介入心臟器材市场评估：依产品类型、最终用户、地区、机会、预测（2017-2031）

Interventional Cardiology Devices Market Assessment, By Product Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 225 Pages | 商品交期: 3-5个工作天内

价格

全球介入心臟器材市场规模预计将从 2023 年的 162.2 亿美元增长到 2031 年的 308.6 亿美元，预测期内复合年增长率为 8.37%。

心血管疾病盛行率不断上升、心臟器械技术进步、监管部门批准数量不断增加、老年人口不断增加、人们对心臟病和治疗选择的认识不断提高、医疗保健支出增加等。介入心臟器械市场正呈现稳定成长的原因与下列因素有关： 政府减轻心臟病负担、加强医疗基础设施的举措以及非营利医疗组织的捐赠也为市场的成长做出了积极贡献。

心臟设备的技术进步

近年来，介入心臟设备的技术进步令人瞩目。 这些进步包括使用机器人技术、小型外科医生控制的手术机器人、提高精度的导航感测器以及带有生物感测器的无线技术。 此外，机器人经皮冠状动脉介入治疗 (PCI) 技术的改进也体现在导线操作、引导导管控制和 IVUS 影像方面。 此外，无线技术和生物感测器在心臟介入方面具有广阔的前景，因为它们可用于监测和诊断等各种应用。

心血管疾病盛行率增加

心血管疾病是全球主要死亡原因，估计每年夺走 1,790 万人的生命。 由于人口增长和老化等因素，心血管疾病的盛行率预计将显着增加。 心血管疾病患者数量的增加是由于缺乏将有关心血管疾病和危险因素的现有知识转化为实践。 心血管疾病的负担在低收入和中等收入国家尤其沉重，导致贫穷并造成沉重的经济负担。 不健康的饮食、缺乏身体活动、吸烟和饮酒是心血管疾病最重要的行为危险因子。 随着心血管疾病盛行率的不断增加，心臟介入器材的需求预计将大幅增加。

北美成为主导地区

北美预计将成为介入心臟设备的领先地区。 该地区心血管疾病发生率较高，导致对心臟设备的需求量大。 此外，北美微创手术的采用率很高，并且在介入心臟设备市场上拥有大量顶级製造商。 北美不断增长的医疗保健支出和高可支配收入也有助于该地区在市场上的主导地位。

本报告调查了全球介入心臟器材市场，提供了市场定义和概述、市场规模趋势和预测、各个细分市场和地区的详细分析、行业结构以及对市场成长的影响。它总结了因素分析、案例研究、竞争格局、主要公司概况等

目录

第 1 章研究方法

第 2 章专案范围与定义

第 3 章执行摘要

第 4 章全球心臟介入器材市场展望

  • 市场规模/预测
  • 依产品类型
    • 支架
    • 导管
    • 气球
    • 护套
    • 阀门
    • 配件/其他
  • 按最终用户
    • 医院
    • 门诊手术中心
    • 心臟诊所
  • 按地区
    • 北美
    • 欧洲
    • 亚太地区
    • 南美洲
    • 中东/非洲
  • 各公司的市占率

第 5 章全球介入心臟器材市场展望：按地区

  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲
  • 中东/非洲

第 6 章市场映射

  • 依产品类型
  • 按最终用户
  • 按地区

第 7 章宏观环境与产业结构

  • 需求与供给分析
  • 汇入/汇出分析
  • 价值链分析
  • PESTEL 分析
  • 波特五力分析

第 8 章市场动态

  • 生长促进因素
  • 生长抑制因素（问题/抑制因素）

第 9 章法律与监管架构/创新

  • 临床试验
  • 专利环境
  • 监理机关核准
  • 创新/新兴技术

第 10 章主要公司状况

  • 前 5 名市场领导者的竞争矩阵
  • 前 5 位市场领导者的市场收入分析
  • 併购/合资企业（如果适用）
  • SWOT 分析（5 家参与公司）

第 11 章价格分析

第 12 章案例研究

第 13 章主要公司展望

  • Abbott Laboratories
  • Terumo Corporation
  • Teleflex Incorporated
  • B. Braun SE
  • Biosensors International Group
  • ACIST Medical Systems
  • Cook Medical
  • Merit Medical Systems
  • Boston Scientific Corporation
  • Medtronic plc

第 14 章策略建议

第 15 章关于我们公司/免责声明

Product Code: MX11065

Global interventional cardiology devices market is projected to witness a CAGR of 8.37% during the forecast period 2024-2031, growing from USD 16.22 billion in 2023 to USD 30.86 billion in 2031. The interventional cardiology devices market is thriving due to factors like a growing prevalence of cardiovascular disorders, technological advancements in cardiology devices, an increasing number of regulatory approvals, a growing geriatric population, rising awareness about cardiac conditions and treatment options, and increasing healthcare expenditure. Government initiatives and contributions from non-profit medical organizations to reduce the cardiac disease burden and strengthen the healthcare infrastructure are some other factors positively impacting the interventional cardiology devices market growth.

However, the dominance of first-line alternative treatment options pushes back the demand for interventional cardiology devices. The high cost of surgical procedures and instruments used for cardiac surgery makes it the terminal choice for middle and lower-class patients. Alongside, risks associated with cardiac surgeries and interventional devices hinder the growth of this market.

In November 2023, Argon Medical Devices, a trusted provider of device solutions for interventional radiology, vascular surgery, interventional cardiology, and oncology, introduced the Kodiak Dual Port Coaxial Introducer Kit. This innovative kit enables precise and streamlined introduction of diagnostic and therapeutic devices into the vasculature, ensuring optimum results for patients.

Technological Advancements in Cardiology Devices

Technological advancements in interventional cardiology devices have been significant in recent years. These advancements include the use of robotic technologies, miniature surgical robots controlled by surgeons, navigational sensors for precision, and wireless technologies with biosensors. Additionally, advancements in robotic percutaneous coronary intervention (PCI) technology, including improvements in wire manipulation, guide catheter control, and IVUS imaging, have been observed. Furthermore, wireless technologies and biosensors hold promise for interventional cardiology, as they can be used for various applications such as monitoring and diagnosis. These advancements are enhancing the precision, safety, and effectiveness of interventional cardiology procedures, ultimately benefiting interventional cardiology devices. Key players are designing products with enhanced technologies to cater to the market needs.

In September 2023, Canon Medical launched the Alphenix Sky 12 HD interventional system with the new high-definition (Hi-Def) detector. The Alphenix Sky 12 HD features a 12"X12" Hi-Def detector to improve visualization for interventional procedures, including pediatric cases, in cardiology, neurology, oncology, and radiology.

Growing Prevalence of Cardiovascular Diseases

Cardiovascular diseases are the leading cause of death globally, taking an estimated 17.9 million lives each year. The prevalence of cardiovascular diseases is expected to increase substantially due to factors such as population growth and aging. The rise in cardiovascular disease cases is attributed to a lack of translation of existing knowledge about cardiovascular diseases and risk factors into practice. The burden of cardiovascular diseases is particularly heavy on low- and middle-income countries, where they contribute to poverty and place a significant economic strain. Unhealthy diet, physical inactivity, tobacco use, and alcohol consumption are among the most important behavioral risk factors for cardiovascular diseases. The demand for interventional cardiology devices is expected to increase significantly with the growing prevalence of cardiovascular diseases.

For instance, according to the World Heart Report 2023 published by the World Heart Federation, cardiovascular diseases have been the leading cause of death worldwide for many years. In 2021, more than 20 million people died from a cardiovascular condition, which accounted for about one-third of all global deaths. This figure is significantly higher than the 12.1 million cardiovascular disease deaths recorded in 1990. Ischemic heart disease is now the leading cause of premature death in 146 countries for men and 98 countries for women.

Dominance of Stents Segment

The stents segment is anticipated to be the leading segment in the interventional cardiology devices market. Stents are commonly used in interventional cardiology to treat coronary artery disease. They are expandable tubular metallic devices introduced into clogged coronary arteries, a procedure known as percutaneous coronary intervention (PCI) or coronary stenting. The most widely used stents are drug-eluting stents (DES), which have significantly reduced the incidence of restenosis in native stable coronary arteries. Stents have been shown to reduce angina and improve survival in patients with coronary artery disease. Innovative stent products from market players have significantly developed the market.

In October 2023, Medinol announced the United States Food and Drug Administration (FDA) approval for its EluNIR-PERL drug-eluting stent (DES), which is meant for the treatment of coronary artery disease. EluNIR-PERL has four radiopaque markers, two at each end, and a hybrid polymer-metal radiopaque catheter tip. These unique features allow excellent visualization during PCI procedures, whether navigating through complex anatomies or placing the stent precisely.

Ambulatory Surgical Centers to be the Fastest Growing End-user Segment

Cardiology procedures are increasingly being performed in ambulatory surgery centers (ASCs) due to various factors such as improved patient experiences, strong reimbursement rates, and cost savings. These procedures include the placement of pacemakers, loop recorders, AICD, diagnostic and interventional coronary procedures, peripheral vascular interventions, right and left heart catheterizations, coronary interventions, and defibrillator and pacemaker implants. The Centers for Medicare and Medicaid Services (CMS) support this shift to ASCs by adding cardiology procedures to the ASC-covered procedure list. This has led to a faster growth rate for ambulatory surgical centers. For instance, as per an article published by HMP Global in July 2023, around 2% of major cardiovascular procedures are being performed in ambulatory surgical centers and the traction is steadily rising.

North America to be the Dominating Region

North America is anticipated to be the leading region in interventional cardiology devices. The region has a high prevalence of cardiovascular diseases, leading to a significant demand for cardiology devices. Additionally, North America has a high adoption rate of minimally invasive procedures and a strong presence of top manufacturers in the interventional cardiology device market. The rising healthcare expenditure and high disposable incomes in North America also contribute to the dominance of the region in the interventional cardiology devices market. Alongside, prominent players in the interventional cardiology device market, such as Medtronic, Boston Scientific Corporation, and Abbott, have a strong presence in North America, further contributing to its dominance.

As per the American Heart Association, by 2035, almost 45% of the United States population is expected to experience heart disease due to unhealthy factors such as high obesity rates, smoking, and poor lifestyle choices. These factors may increase the risk of heart attacks and other related health issues.

Future Market Scenario (2024 - 2031F)

In recent years, notable regulatory emphasis has been helpful for novel marketed products. Several reforms have been made to speed up the approval process of interventional cardiology devices. The FDA has been granting several regulatory approvals for interventional cardiology devices. The classification of interventional cardiovascular implant simulation software devices has been updated to class II (special controls). Most class III devices require FDA approval of a PMA before they can be legally marketed. The classification of cardiovascular devices intended for human use that are in commercial distribution is outlined in 21 CFR Part 870. The number of cardiac device approvals for children seems to be growing, with most approvals being granted through the humanitarian device exemption (HDE) pathway.

In November 2023, Medtronic plc received approval from the United States Food and Drug Administration (FDA) for its Symplicity Spyral renal denervation (RDN) system, which is also known as the Symplicity blood pressure procedure. This system has been approved for use in treating hypertension. As a result of the approval, Medtronic will start the commercialization of the product right away. The device is mainly meant to reduce hypertension through relaxing nerves connected to the kidneys and reducing its activity.

Key Players Landscape and Outlook

The key players in the interventional cardiology devices market include Abbott Laboratories, Terumo Corporation, Teleflex Incorporated, and B. Braun SE, among others. Many companies are working on developing new products and expanding their business through collaborations, partnerships, mergers, and strategic alliances. The market value of these players is driven by the successful implementation of these strategies. Additionally, regulatory approvals for new products and services also contribute to the growth of both the players and the market.

In October 2023, Haemonetics offered USD 253 million for sensor equipped TAVR guidewire maker OpSens. The deal is expected to close in January 2024. Haemonetics is a Boston-based medical device maker, while OpSens is a Canadian developer of optical sensor-equipped devices for both medical and industrial uses.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Interventional Cardiology Devices Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Product Type
    • 4.2.1. Stents
      • 4.2.1.1. Bare-Metal Stents
      • 4.2.1.2. Drug-Eluting Stents
      • 4.2.1.3. Bio Absorbable Stent
      • 4.2.1.4. Others
    • 4.2.2. Catheters
      • 4.2.2.1. Angiography Catheters
      • 4.2.2.2. Atherectomy Catheters
      • 4.2.2.3. Thrombectomy Catheters
      • 4.2.2.4. Ablation Catheters
      • 4.2.2.5. IVUS Catheters
      • 4.2.2.6. Others
    • 4.2.3. Balloons
      • 4.2.3.1. PTCA Balloons
      • 4.2.3.2. Valvuloplasty Balloons
      • 4.2.3.3. Others
    • 4.2.4. Sheaths
    • 4.2.5. Valves
    • 4.2.6. Accessories and others
  • 4.3. By End-user
    • 4.3.1. Hospitals
    • 4.3.2. Ambulatory Surgical Centers
    • 4.3.3. Cardiology Clinics
  • 4.4. By Region
    • 4.4.1. North America
    • 4.4.2. Europe
    • 4.4.3. Asia-Pacific
    • 4.4.4. South America
    • 4.4.5. Middle East and Africa
  • 4.5. By Company Market Share (%), 2023

5. Global Interventional Cardiology Devices Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Product Type
      • 5.1.2.1. Stents
      • 5.1.2.1.1. Bare-Metal Stents
      • 5.1.2.1.2. Drug-Eluting Stents
      • 5.1.2.1.3. Bio Absorbable Stent
      • 5.1.2.1.4. Others
      • 5.1.2.2. Catheters
      • 5.1.2.2.1. Angiography Catheters
      • 5.1.2.2.2. Atherectomy Catheters
      • 5.1.2.2.3. Thrombectomy Catheters
      • 5.1.2.2.4. Ablation Catheters
      • 5.1.2.2.5. IVUS Catheters
      • 5.1.2.2.6. Others
      • 5.1.2.3. Balloons
      • 5.1.2.3.1. PTCA Balloons
      • 5.1.2.3.2. Valvuloplasty Balloons
      • 5.1.2.3.3. Others
      • 5.1.2.4. Sheaths
      • 5.1.2.5. Valves
      • 5.1.2.6. Accessories and others
    • 5.1.3. By End-user
      • 5.1.3.1. Hospitals
      • 5.1.3.2. Ambulatory Surgical Centers
      • 5.1.3.3. Cardiology Clinics
    • 5.1.4. United States*
      • 5.1.4.1. Market Size & Forecast
      • 5.1.4.1.1. By Value
      • 5.1.4.1.2. By Volume
      • 5.1.4.2. By Product Type
      • 5.1.4.2.1. Stents
      • 5.1.4.2.1.1. Bare-Metal Stents
      • 5.1.4.2.1.2. Drug-Eluting Stents
      • 5.1.4.2.1.3. Bio Absorbable Stent
      • 5.1.4.2.1.4. Others
      • 5.1.4.2.2. Catheters
      • 5.1.4.2.2.1. Angiography Catheters
      • 5.1.4.2.2.2. Atherectomy Catheters
      • 5.1.4.2.2.3. Thrombectomy Catheters
      • 5.1.4.2.2.4. Ablation Catheters
      • 5.1.4.2.2.5. IVUS Catheters
      • 5.1.4.2.2.6. Others
      • 5.1.4.2.3. Balloons
      • 5.1.4.2.3.1. PTCA Balloons
      • 5.1.4.2.3.2. Valvuloplasty Balloons
      • 5.1.4.2.3.3. Others
      • 5.1.4.2.4. Sheaths
      • 5.1.4.2.5. Valves
      • 5.1.4.2.6. Accessories and others
      • 5.1.4.3. By End-user
      • 5.1.4.3.1. Hospitals
      • 5.1.4.3.2. Ambulatory Surgical Centers
      • 5.1.4.3.3. Cardiology Clinics
    • 5.1.5. Canada
    • 5.1.6. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East & Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Product Type
  • 6.2. By End-user
  • 6.3. By Region

7. Macro Environment and Industry Structure

  • 7.1. Demand Supply Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Abbott Laboratories
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products & Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus & Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Terumo Corporation
  • 13.3. Teleflex Incorporated
  • 13.4. B. Braun SE
  • 13.5. Biosensors International Group
  • 13.6. ACIST Medical Systems
  • 13.7. Cook Medical
  • 13.8. Merit Medical Systems
  • 13.9. Boston Scientific Corporation
  • 13.10. Medtronic plc

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 3. Global Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 4. Global Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 5. Global Interventional Cardiology Devices Market Share (%), By Region, 2017-2031F
  • Figure 6. North America Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 7. North America Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 8. North America Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 9. North America Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 10. North America Interventional Cardiology Devices Market Share (%), By Country, 2017-2031F
  • Figure 11. United States Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 12. United States Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 13. United States Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 14. United States Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 15. Canada Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. Canada Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 17. Canada Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 18. Canada Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 19. Mexico Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 20. Mexico Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 21. Mexico Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 22. Mexico Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 23. Europe Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 24. Europe Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 25. Europe Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 26. Europe Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 27. Europe Interventional Cardiology Devices Market Share (%), By Country, 2017-2031F
  • Figure 28. Germany Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 29. Germany Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 30. Germany Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 31. Germany Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 32. France Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 33. France Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 34. France Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 35. France Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 36. Italy Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 37. Italy Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 38. Italy Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 39. Italy Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 40. United Kingdom Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. United Kingdom Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 42. United Kingdom Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 43. United Kingdom Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 44. Russia Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 45. Russia Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 46. Russia Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 47. Russia Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 48. Netherlands Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 49. Netherlands Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 50. Netherlands Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 51. Netherlands Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 52. Spain Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Spain Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 54. Spain Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 55. Spain Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 56. Turkey Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 57. Turkey Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 58. Turkey Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 59. Turkey Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 60. Poland Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 61. Poland Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 62. Poland Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 63. Poland Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 64. South America Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. South America Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 66. South America Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 67. South America Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 68. South America Interventional Cardiology Devices Market Share (%), By Country, 2017-2031F
  • Figure 69. Brazil Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 70. Brazil Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 71. Brazil Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 72. Brazil Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 73. Argentina Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 74. Argentina Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 75. Argentina Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 76. Argentina Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 77. Asia-Pacific Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 78. Asia-Pacific Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 79. Asia-Pacific Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 80. Asia-Pacific Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 81. Asia-Pacific Interventional Cardiology Devices Market Share (%), By Country, 2017-2031F
  • Figure 82. India Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. India Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 84. India Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 85. India Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 86. China Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 87. China Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 88. China Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 89. China Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 90. Japan Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 91. Japan Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 92. Japan Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 93. Japan Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 94. Australia Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. Australia Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 96. Australia Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 97. Australia Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 98. Vietnam Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 99. Vietnam Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 100. Vietnam Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 101. Vietnam Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 102. South Korea Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 103. South Korea Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 104. South Korea Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 105. South Korea Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 106. Indonesia Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 107. Indonesia Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 108. Indonesia Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 109. Indonesia Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 110. Philippines Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 111. Philippines Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 112. Philippines Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 113. Philippines Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 114. Middle East & Africa Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 115. Middle East & Africa Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 116. Middle East & Africa Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 117. Middle East & Africa Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 118. Middle East & Africa Interventional Cardiology Devices Market Share (%), By Country, 2017-2031F
  • Figure 119. Saudi Arabia Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 120. Saudi Arabia Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 121. Saudi Arabia Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 122. Saudi Arabia Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 123. UAE Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 124. UAE Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 125. UAE Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 126. UAE Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 127. South Africa Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 128. South Africa Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 129. South Africa Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 130. South Africa Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
  • Figure 131. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 132. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 133. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023